JPMorgan Chase & Co. Increases U.S. Physical Therapy (NYSE:USPH) Price Target to $120.00

U.S. Physical Therapy (NYSE:USPHGet Free Report) had its target price upped by analysts at JPMorgan Chase & Co. from $117.00 to $120.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective indicates a potential upside of 20.26% from the stock’s previous close.

A number of other brokerages have also weighed in on USPH. Bank of America restated a “neutral” rating and issued a $90.00 target price (down from $114.00) on shares of U.S. Physical Therapy in a research note on Monday, October 7th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research report on Wednesday, August 21st. Finally, Barrington Research reiterated an “outperform” rating and set a $108.00 price objective on shares of U.S. Physical Therapy in a research report on Thursday, November 21st.

Get Our Latest Report on USPH

U.S. Physical Therapy Stock Performance

Shares of USPH opened at $99.79 on Tuesday. The stock has a market capitalization of $1.51 billion, a price-to-earnings ratio of 106.15, a price-to-earnings-growth ratio of 4.49 and a beta of 1.46. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The stock’s 50-day simple moving average is $87.54 and its 200 day simple moving average is $90.31. U.S. Physical Therapy has a 52-week low of $76.18 and a 52-week high of $113.63.

Insider Activity

In other U.S. Physical Therapy news, Director Bernard A. Harris, Jr. sold 2,000 shares of the business’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total value of $185,900.00. Following the sale, the director now directly owns 16,726 shares of the company’s stock, valued at approximately $1,554,681.70. The trade was a 10.68 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nancy Ham sold 1,172 shares of the business’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total value of $113,355.84. Following the completion of the sale, the director now directly owns 1,112 shares in the company, valued at $107,552.64. This trade represents a 51.31 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,896 shares of company stock worth $656,940 in the last quarter. 1.70% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. State Street Corp increased its position in U.S. Physical Therapy by 17.5% during the third quarter. State Street Corp now owns 667,868 shares of the company’s stock valued at $56,522,000 after acquiring an additional 99,244 shares during the last quarter. Southernsun Asset Management LLC increased its position in U.S. Physical Therapy by 10.5% during the third quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after acquiring an additional 52,062 shares during the last quarter. Dimensional Fund Advisors LP increased its position in U.S. Physical Therapy by 2.5% during the second quarter. Dimensional Fund Advisors LP now owns 423,846 shares of the company’s stock valued at $39,173,000 after acquiring an additional 10,462 shares during the last quarter. Geode Capital Management LLC increased its position in U.S. Physical Therapy by 1.3% during the third quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock valued at $29,040,000 after acquiring an additional 4,477 shares during the last quarter. Finally, Envestnet Asset Management Inc. increased its position in U.S. Physical Therapy by 4.1% during the second quarter. Envestnet Asset Management Inc. now owns 239,982 shares of the company’s stock valued at $22,179,000 after acquiring an additional 9,434 shares during the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Articles

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.